Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - lipegfilgrastim, quantity: 6 mg - injection, solution - excipient ingredients: acetic acid; polysorbate 20; sorbitol; sodium hydroxide; water for injections - lonquex? is indicated for reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - lipegfilgrastim - solution for injection - 10mg/1ml

Singapore - English - HSA (Health Sciences Authority)

teva pharmaceutical investments singapore pte. ltd. - lipegfilgrastim - injection, solution - lipegfilgrastim 6.00 mg/0.6ml

Israel - English - Ministry of Health

abic marketing ltd, israel - lipegfilgrastim - solution for injection - lipegfilgrastim 6 mg / 0.6 ml - lipegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd s.p.a. - a/brisbane/59/2007 (h1n1) - like strain (a/brisbane/59/2007, ivr-148) ph.eur a/brisbane/10/2007 (h3n2) - like strain (a/uruguay/716/2007,nymc x-175-c) b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - solution for injection - 250 %v/v

Ireland - English - HPRA (Health Products Regulatory Authority)

mylan products limited - a/michigan/45/2015 (h1n1) pdm09 - like strain (a/singapore/gp1908/2015, ivr-180a), a/hong kong/4801/2014 (h3n2) - like strain (a/hong kong/4801/2014, nymc x-263b), b/phuket/3073/2013 -like strain (b/phuket/3073/2013, wild type), b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - solution for injection in pre-filled syringe - 15 microgram - influenza vaccines

Canada - English - Health Canada

biocryst pharmaceuticals inc - peramivir - solution - 10mg - peramivir 10mg - neuraminidase inhibitors

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd s.p.a. - a/brisbane/59/2007 (h1n1) - like strain (a/brisbane/59/2007, ivr-148) ph.eur a/brisbane/10/2007 (h3n2) - like strain (a/uruguay/716/2007,nymc x-175-c) b/brisbane/60/2008 - like strain (b/brisbane/60/2008) - solution for injection - 250 %v/v

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

janssen-cilag ltd - hepatitis a virus inactivated - emulsion for injection

European Union - English - EMA (European Medicines Agency)

glaxosmithkline trading services limited - zanamivir - influenza, human - antivirals for systemic use - dectova is indicated for the treatment of complicated and potentially life-threatening influenza a or b virus infection in adult and paediatric patients (aged ≥6 months) when:the patient’s influenza virus is known or suspected to be resistant to anti-influenza medicinal products other than zanamivir, and/orother anti-viral medicinal products for treatment of influenza, including inhaled zanamivir, are not suitable for the individual patient.dectova should be used in accordance with official guidance.